Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis-Reference-Cited by-同舟云学术

Impact of non-adherence to direct oral anticoagulants amongst Swedish patients with non-valvular atrial fibrillation: results from a real-world cost-utility analysis

Published:2022-09-07 Issue:1 Volume:25 Page:1085-1091
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Blomström Lundqvist Carina¹,Själander Sara²,Garcia Rodriguez Luis A.³^ORCID,Åkerborg Örjan⁴,Jin Guanyi⁴,Caleyachetty Amrit⁴^ORCID,Huelsebeck Maria⁵,Bowrin Kevin⁶^ORCID,Schaefer Bernhard⁵,Mahdessian Hovsep⁷,Hofmeister Lucas⁵,Levin Lars-Åke⁸

Affiliation:

1. Department of Cardiology, School of Medical Sciences, Faculty of Medicine and Health, Örebro University, Örebro, Sweden

2. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden

3. Spanish Centre for Pharmacoepidemiologic Research (CEIFE), Madrid, Spain

4. Wickenstones Ltd., Carlow, Ireland

5. Bayer AG, Berlin, Germany

6. Bayer Plc, Reading, UK

7. Bayer AB, Stockholm, Sweden

8. Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden

Publisher

Informa UK Limited

Subject